ReleVote

Women and Lung Cancer Research and Preventive Services Act of 2025

Bill Number
S. 1157
Origin Chamber
Senate
Congress
119th Congress, Session 2
Policy Area
Health
Status
Passed Senate
Latest Action
2026-06-09: Held at the desk.
Last Updated
2026-06-16T18:01:31Z

AI-Generated Summary

Women and Lung Cancer Research and Preventive Services Act of 2025

Purpose

This legislation directs the Secretary of Health and Human Services to lead an interagency review of federal efforts on lung cancer research, prevention, diagnosis, and treatment. The goal is to identify knowledge gaps, improve health outcomes for women and populations with few known risk factors, and increase screening rates among those recommended for screening by the United States Preventive Services Task Force.

Key Provisions

Significant Changes to Existing Law

The Act creates a new statutory requirement for a targeted interagency review and report. It does not amend or repeal existing statutes but adds a specific mandate to evaluate and potentially update federal programs and strategic plans related to lung cancer.

Potential Impacts

Main Stakeholders Affected

Notable Legal, Constitutional, or Political Implications

The legislation represents a standard exercise of congressional oversight by directing executive branch review and reporting. No significant constitutional issues, such as separation of powers concerns, are evident in the text.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Sen. Smith, Tina [D-MN]

Cosponsors (7)

Sen. Capito, Shelley Moore [R-WV], Sen. Hirono, Mazie K. [D-HI], Sen. Collins, Susan M. [R-ME], Sen. Ossoff, Jon [D-GA], Sen. Merkley, Jeff [D-OR], Sen. Cantwell, Maria [D-WA], Sen. Klobuchar, Amy [D-MN]

Recent Actions

Bill Versions

Related Bills